Charles Schwab’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$135M Buy
1,075,757
+56,538
+6% +$7.1M 0.02% 538
2025
Q1
$139M Buy
1,019,219
+47,956
+5% +$6.56M 0.03% 499
2024
Q4
$149M Buy
971,263
+58,234
+6% +$8.91M 0.03% 476
2024
Q3
$177M Buy
913,029
+12,319
+1% +$2.39M 0.03% 409
2024
Q2
$209M Buy
900,710
+41,905
+5% +$9.71M 0.04% 372
2024
Q1
$185M Buy
858,805
+9,805
+1% +$2.11M 0.04% 375
2023
Q4
$220M Buy
849,000
+310
+0% +$80.2K 0.06% 302
2023
Q3
$218M Sell
848,690
-1,511
-0.2% -$388K 0.06% 277
2023
Q2
$242M Buy
850,201
+5,819
+0.7% +$1.66M 0.07% 239
2023
Q1
$235M Buy
844,382
+8,088
+1% +$2.25M 0.07% 242
2022
Q4
$232M Buy
836,294
+15,726
+2% +$4.35M 0.07% 242
2022
Q3
$219M Buy
820,568
+30,684
+4% +$8.19M 0.08% 230
2022
Q2
$161M Buy
789,884
+25,124
+3% +$5.12M 0.06% 309
2022
Q1
$161M Buy
764,760
+23,023
+3% +$4.85M 0.05% 349
2021
Q4
$178M Buy
741,737
+10,539
+1% +$2.53M 0.05% 333
2021
Q3
$207M Buy
731,198
+7,369
+1% +$2.09M 0.07% 258
2021
Q2
$251M Buy
723,829
+19,565
+3% +$6.77M 0.08% 209
2021
Q1
$197M Sell
704,264
-6,138
-0.9% -$1.72M 0.07% 243
2020
Q4
$174M Sell
710,402
-24,678
-3% -$6.04M 0.07% 259
2020
Q3
$209M Sell
735,080
-90,630
-11% -$25.7M 0.1% 192
2020
Q2
$221M Sell
825,710
-112,088
-12% -$30M 0.11% 178
2020
Q1
$297M Buy
937,798
+3,467
+0.4% +$1.1M 0.17% 111
2019
Q4
$277M Sell
934,331
-33,539
-3% -$9.95M 0.15% 122
2019
Q3
$225M Buy
967,870
+36,633
+4% +$8.53M 0.13% 144
2019
Q2
$218M Buy
931,237
+14,919
+2% +$3.49M 0.13% 142
2019
Q1
$217M Buy
916,318
+6,944
+0.8% +$1.64M 0.14% 133
2018
Q4
$274M Buy
909,374
+21,321
+2% +$6.42M 0.21% 87
2018
Q3
$314M Sell
888,053
-32,534
-4% -$11.5M 0.21% 81
2018
Q2
$267M Buy
920,587
+28,440
+3% +$8.25M 0.19% 87
2018
Q1
$244M Buy
892,147
+59,509
+7% +$16.3M 0.19% 92
2017
Q4
$265M Buy
832,638
+56,333
+7% +$17.9M 0.21% 82
2017
Q3
$243M Sell
776,305
-22,164
-3% -$6.94M 0.21% 79
2017
Q2
$217M Sell
798,469
-41,171
-5% -$11.2M 0.2% 89
2017
Q1
$230M Buy
839,640
+60,754
+8% +$16.6M 0.23% 76
2016
Q4
$221M Buy
778,886
+33,444
+4% +$9.48M 0.24% 69
2016
Q3
$233M Buy
745,442
+96,902
+15% +$30.3M 0.27% 60
2016
Q2
$157M Buy
648,540
+14,973
+2% +$3.62M 0.2% 96
2016
Q1
$165M Sell
633,567
-4,293
-0.7% -$1.12M 0.22% 82
2015
Q4
$195M Sell
637,860
-23,873
-4% -$7.31M 0.26% 72
2015
Q3
$193M Sell
661,733
-45,829
-6% -$13.4M 0.28% 64
2015
Q2
$286M Buy
707,562
+12,205
+2% +$4.93M 0.39% 48
2015
Q1
$294M Buy
695,357
+33,022
+5% +$13.9M 0.41% 46
2014
Q4
$225M Buy
662,335
+15,009
+2% +$5.09M 0.34% 53
2014
Q3
$214M Buy
647,326
+36,029
+6% +$11.9M 0.35% 50
2014
Q2
$193M Sell
611,297
-11,641
-2% -$3.67M 0.32% 57
2014
Q1
$191M Buy
622,938
+23,423
+4% +$7.16M 0.34% 53
2013
Q4
$168M Buy
599,515
+18,203
+3% +$5.09M 0.32% 59
2013
Q3
$142M Buy
581,312
+71,066
+14% +$17.4M 0.29% 69
2013
Q2
$111M Buy
+510,246
New +$111M 0.25% 81